Leadless cardiac pacemaker is a type of a medical equipment that is utilized for treating patients suffering from heart related issues such as arrhythmias. It is a medical device that utilizes electrical impulses, which are artificially generated by its electrodes. These artificial electrical impulses help in regulating the heart beat at normal state. This equipment is generally suggested for people suffering from heart conditions such as tachycardia, arrhythmia, and heart block among others. Leadless cardiac pacemaker is specially designed to deliver similar pacing results. However, the procedure of implantation of this type of pacemaker is slightly different from the regular ones. For a regular pacemaker, a surgical pocket needs to be created for implantation. Later, leads are attached to it. However, for leadless cardiac pacemaker, no such surgical pockets are required, nor does it require any later leads attachments.
The pacemaker is projected to have a considerable impact on the global cardiac rhythm management (CRM) market over the next few years. Leadless cardiac pacemakers have a huge potential to cut down the complications related to heart surgeries and also provide shorter recovery periods.
Some of the key developments in the global leadless cardiac pacemaker market are given below:
There are several factors that are influencing the growth of the global leadless cardiac pacemaker market. Some of these factors are listed below as follows:
The global leadless cardiac pacemaker market is segmented into key regions such as Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. Of these, the global market is expected to be dominated by the North America region over the course of the given forecast period of 2010 to 2027. This growth of the leadless cardiac pacemaker market is primarily attributed to the growing prevalence of cardiovascular disorders, increasing adoption of leadless pacemakers, and the easy availability of insurance reimbursements.